T. Tillett

Management of uncommon chemotherapy-induced emergencies.

J. Braybrooke, T. Ajithkumar, C. Morgan, 2011, The Lancet. Oncology.

Radiological assessment of response and adverse events associated with novel systemic oncological therapies.

K. D. De Paepe, A. Andreou, M. Beresford, 2021, Clinical radiology.

Thromboembolic events with cisplatin-based neoadjuvant chemotherapy for transitional cell carcinoma of urinary bladder.

D. Gillatt, E. Rowe, R. Persad, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer

H. Grabsch, S. Grumett, P. Hall, 2021, JAMA oncology.

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.

T. Roques, S. Grumett, M. Middleton, 2022, JAMA oncology.

Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial.

H. Grabsch, S. Grumett, P. Hall, 2019, Journal of Clinical Oncology.

A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)

T. Roques, S. Grumett, R. Roylance, 2023, Scientific reports.

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

A. Mammen, H. Mann, L. Saketkoo, 2023, Nature Reviews Rheumatology.